With the popularity of glucagon-like peptide 1 receptor agonists (GLP-1 agonists) like Ozempic, you may have seen advertisements for compounded semaglutide
Mod GRF 1-29, also referred to as Mod GRF 1-29, has been investigated as an analog of somatocrinin, with potential to stimulate growth hormone-releasing hormone (GHRH) receptors
doi:10.1016/j.freeradbiomed.2021.11.010 179
In summary, a single bout of resistance exercise likely leads to robust and transient increases in circulating BDNF, which may be leveraged in chronic RT interventions with repeated bouts to improve and/or protect brain health with aging
Suppression of testosterone does not blunt mRNA expression of myoD, myogenin, IGF, myostatin or androgen receptor post strength training in humans
Suppression of prostate cancer metastasis by DPYSL3-targeted saRNA